Drugs, Medicare, Medicare costs

Looking For Lower Medicare Drug Costs? Ask Your Pharmacist For The Cash Price.

Sometimes a drug plan’s copay is higher than the cash, but insurers’ “gag orders” keep pharmacists from telling Medicare beneficiaries. A little-known Medicare rule requires pharmacists to divulge the lower cash price if patients ask.

By Susan Jaffe  | Kaiser Health News | May 30, 2018 | This KHN story also ran on 

As part of President Donald Trump’s blueprint to bring down prescription costs, Medicare officials have warned insurers that “gag orders” 

Scott Olson/Getty Images

keeping pharmacists from alerting seniors that they could save money by paying cash — rather than using their insurance — are “unacceptable and contrary” to the government’s effort to promote price transparency.

But the agency stopped short of requiring insurers to lift such restrictions on pharmacists.

That doesn’t mean people with Medicare drug coverage are destined to overpay for prescriptions. Under a little-known Medicare rule, they can pay a lower cash price for prescriptions instead of using their insurance. But first, they must ask the pharmacist about that option…. [Continued at Kaiser Health News, NPR and CNN Money]

CDC, HHS, NIH, The Lancet

Gun violence research in the USA: the CDC’s impasse

Volume 391, Number 10139   

 23 June 2018

 

WORLD REPORT   Months after the Trump Administration said that there is no ban on gun violence studies, the CDC still lacks the funding to proceed. Susan Jaffe, The Lancet‘s Washington correspondent, reports.

…Appeals for immediate federal action to make schools and communities safer have so far largely gone unanswered. And legislative efforts languish in Congress, as the chairman of a key congressional committee that oversees federal health programmes has so far resisted requests by its Democratic members to hold hearings on preventing gun violence [continued here].

Drugs, FDA, HHS, The Lancet

Trump unveils plan to cut drug prices

 Volume 391, Number 10136   

 2 June 2018

 

WORLD REPORT   The president’s wide-ranging plan to reduce prescription drug prices won’t be easy to achieve, experts say. Susan Jaffe, The Lancet’s Washington correspondent, reports.

“We will have tougher negotiation, more competition, and much lower prices at the pharmacy counter. And it will start to take effect very soon“, said President Donald Trump.  

How soon will depend on what steps the administration takes on its own, through regulations and other mandates, and what changes can only be achieved through new laws enacted by Congress, which will increasingly be preoccupied by November’s election. [Continued here.]

EPA, The Lancet

Besieged EPA Chief still committed to Trump agenda

Susan Jaffe | Washington Correspondent for The Lancet | 8th May 2018

    At last count, at least four federal agencies were conducting nearly a dozen investigations of Environmental Protection Agency chief Scott Pruitt, probing his office renovations, a round-the-clock security unit who accompanied him on a trip to Disneyland, personnel management, and first-class air travel. The Capitol Hill condo he rented at a bargain rate of only $50 a night from the wife of an energy industry lobbyist has also come under scrutiny.

Environmental Protection Agency Administrator Scott Pruitt testifies at a congressional hearing April 26, 2018 (Getty Images).

But in separate hearings held by the congressional subcommittees that oversee EPA, Pruitt dismissed the investigations as politically motivated. 

“Those who attack the EPA and attack me are doing so because they want to attack and derail the president’s agenda and undermine this administration’s priorities,” Pruitt told the congressional panels two weeks ago. “I am simply not going to let that happen.”

…Republicans were eager to praise his achievements during the hearings, and encouraged him to keep at it. [Continued here] 

EPA, The Lancet

Scientists and physicians run for office in the USA

 Volume 391, Number 10131   

 28 April 2018

 

WORLD REPORT   Frustrated by what they say is the US Government’s disregard for science, more scientists and physicians are entering politics.  Susan Jaffe, The Lancet’s Washington correspondent, reports.

Nuclear engineer Elaine Luria running for Congress in southeast Virginia (photo/elaineforcongress.com)

Scientists, physicians, engineers, and their supporters surprised many people—and maybe themselves—when they assembled in cities across the USA a year ago demanding an end to President Donald Trump’s Administration’s so-called war on science, which has attacked climate change, environmental protection laws, and funds for biomedical research, among other targets.

But, for some critics, protests are not enough. Instead of appealing to elected officials, now they want to take their place.

“…More and more scientists realise that they have… an obligation to see that the idea of science is defended, that evidence is respected, and that the conditions for science to thrive are respected”, said Rush Holt, chief executive officer of the American Association for the Advancement of Science.  [Continued here.] 

Medicaid, Medicare, Medicare Advantage

Medicare Advantage Plans Cleared To Go Beyond Medical Coverage — Even Groceries

By Susan Jaffe  | Kaiser Health News | April 3, 2018 | This KHN story also ran on 

Air conditioners for people with asthma, healthy groceries, rides to medical appointments and home-delivered meals may be among the new benefits added to Medicare Advantage [private insurance] coverage when new federal rules take effect next year. 

The Institute for Aging in San Francisco helps seniors get to doctor appointments and social activities. (Photo/Susan Jaffe)

…But patient advocates including David Lipschutz. senior policy attorney at the Center for Medicare Advocacy, are concerned about those who may be left behind. “It’s great for the people in Medicare Advantage plans, but what about the majority of the people who are in traditional Medicare?” he asked. “As we tip the scales more in favor of Medicare Advantage, it’s to the detriment of people in traditional Medicare.”  [Continued at Kaiser Health News,  The Philadelphia Inquirer,  The Washington Post and CNN Money]

CDC, The Lancet

No barrier to CDC research on gun violence—except funding

Susan Jaffe | Washington Correspondent for The Lancet | 28th March 2018

    A day after the horrific mass shooting at Marjory Stoneman Douglas High School in Parkland, Florida on February 14, where 17 students and faculty were murdered and 14 injured, Health and Human Services Secretary Alex Azar fielded budget questions from a congressional committee. In response to Representative Kathy Castor, a Democrat from Tampa, Florida, Azar said there is no restriction on the ability of the Centers for Disease Control and Prevention (CDC) to conduct research into the causes of gun violence.

Questions about CDC’s ability to investigate gun violence—as it

“March for Our Lives” rally in Washington, D. C. March 24, 2018. (Photo/Susan Jaffe)

would other public health threats—have persisted ever since Congress passed the 1996 Dickey Amendment prohibiting the use of research funds to advocate or promote gun control.

“We don’t believe that it gets in the way of our ability to do violence research or firearms violence research at any part of HHS,” Azar told another congressional panel a month later.  “I think we’ve now made it quite publicly—and within the administration—clear that we don’t see any barriers around violence or firearm violence research.  We’re in the evidence and science-gathering business.”

His assurances were also included in the instructions that accompanied the budget agreement Congress approved and President Donald Trump signed into law last week. While some observers believe this means CDC has permission from Congress to proceed, some leading experts in firearms research are skeptical.  There may be no barriers, but they say there’s no funding either.[Continued here]  

HHS

Trump Administration’s new direction for Medicaid

Volume 391, Number 10126   
24 March 2018

 

WORLD REPORT   Medicaid work requirements would make the health insurance programme a pathway out of poverty, say top US health officials. Susan Jaffe, The Lancet’s Washington correspondent, reports.

Beneficiaries can lose their health care if they fail to pay a premium, submit documentation that they qualify for an exemption, or to report a change in eligibility. “All roads lead to people being terminated from the programme or locked out of coverage,” said Leonardo Cuello, an attorney and director of health policy at the National Health Law Program in Washington, DC.  

“This is not about punishing anyone”, said Arkansas Governor Asa Hutchinson. “It’s about giving people an opportunity to work and give them the training they need and help them move out of poverty and up the economic ladder.”  [Full article here.]   

Drugs, Medicare, Medicare Advantage, Medicare costs, Physical therapy

Lifting Therapy Caps Is A Load Off Medicare Patients’ Shoulders

Last month’s budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.

By Susan Jaffe  | Kaiser Health News | March 14, 2018 | This KHN story also ran on 

Physical therapy helps Leon Beers, 73, get out of bed in the morning and

Leon Beers gets help from caregiver Timothy Wehe. (Bert Johnson for KHN)

maneuver around his home using his walker. Other treatment strengthens his throat muscles so that he can communicate and swallow food, said his sister Karen Morse. But in mid-January, his home health care agency told Morse it could no longer provide these services because he had used all his therapy benefits allowed under Medicare for the year.

… Under a recent change in federal law, people who qualify for Medicare’s [physical, occupational and speech] therapy services will no longer lose them solely because they used too much. 

“It is a great idea,” said Beers. “It will help me get back to walking.” [Continued at Kaiser Health News,  NPR  and The Washington Post]

 

Appeals, Long term care, Medicaid, Medicare, Medicare costs, Physical therapy

Home Care Agencies Often Wrongly Deny Medicare Help To The Chronically Ill

By Susan Jaffe  | Kaiser Health News | January 18, 2018 | This KHN story also ran on     

Colin Campbell    (Heidi de Marco/KHN)

Colin Campbell needs help dressing, bathing and moving between his bed and his wheelchair. He has a feeding tube because his partially paralyzed tongue makes swallowing “almost impossible,”he said.

Campbell, 58, spends $4,000 a month on home health care services so he can continue to live in his home just outside Los Angeles. Eight years ago, he was diagnosed with amyotrophic lateral sclerosis, or “Lou Gehrig’s disease,” which relentlessly attacks the nerve cells in his brain and spinal cord and has no cure.

The former computer systems manager has Medicare coverage because of his disability, but no fewer than 14 home health care providers have told him he can’t use it to pay for their services. That’s an incorrect but common belief….  [Continued at Kaiser Health News and NPR]

CDC, Global Health, The Lancet

CDC faces leadership changes, potential spending cuts

Volume 391, Number 10121   
17 February 2018

 

WORLD REPORT   The CDC has indicated it will reduce its foreign presence, and proposed budget cuts make some fear its core functions are threatened. Susan Jaffe, The Lancet’s Washington correspondent, reports.

“We don’t know what the next outbreak organism will be; we don’t know where it will come from, or when it will emerge”, [former CDC director Dr. Tom] Frieden said. “But we are 100% certain there will be a next one and if we are not better prepared than we were during Ebola, shame on us.”  [Full article here.]

 

CDC, EPA, FDA, HHS, NIH, The Lancet

After a weekend of negotiations and demonstrations, shutdown disrupts health agencies

Susan Jaffe | Washington Correspondent for The Lancet | 22nd January 2018

On the first anniversary of Donald Trump’s inauguration as the 45th president of the United States on January 20, 2018, the federal government ground to a shutdown and hundreds of thousands of women and their supporters rallied against the new president in dozens of cities across the country. [Continued here.]  

 

 

Affordable Care Act, The Lancet

Changes in the US tax system will also affect health care

Volume 391, Number 10117   
20 January 2018

 

WORLD REPORT    The tax overhaul pushed by Republicans could jeopardise the ACA’s health insurance marketplaces. Susan Jaffe, The Lancet’s Washington correspondent, reports.   

…The new tax law contains a provision aimed at an… administration target, the Patient Protection and Affordable Care Act (ACA). Next year, it eliminates the ACA’s tax penalty for Americans who disregard the requirement to have health insurance, one of the law’s most unpopular features. Even though the ACA’s health insurance mandate is still quite intact, Trump and others claim there is effectively no mandate without a penalty.
“When the individual mandate is being repealed, that means Obamacare is being repealed”, Trump said shortly before signing the tax bill into law last month. “And we’ll come up with something that will be much better, whether it’s block grants or whether it’s taking what we have and doing something terrific.”  [full story here]

 

The Lancet

Temporary CHIP funding falls short

Susan Jaffe | Washington Correspondent for The Lancet | 29th December 2017

Despite wide bipartisan support for the Children’s Health Insurance Program (CHIP), Congress agreed last week to continue coverage for 8.9 million children only through the end of Mthe-lancet-usa-blog-logo1arch. But several of the program’s state directors say the $2.85 billion rescue plan won’t even last that long, and federal health officials are not offering much reassurance.  [Continued here.]    Temporary CHIP 122917

Affordable Care Act, HHS, The Lancet

Alex Azar’s controversial qualifications

Susan Jaffe | Washington Correspondent for The Lancet | 27th December 2017

When President Donald Trump nominated Alex Azar last month to lead the Department of Health and Human Services (HHS), supporters said his experience working in government and the pharmaceutical industry more than qualified him for the job. … the-lancet-usa-blog-logo1But critics say Azar has the wrong kind of experience. When he appeared before Senate Committee on Health, Education, Labor and Pensions (HELP) last month, the committee’s senior Democrat Patty Murray of Washington said if Azar runs HHS then “the fox is guarding the hen house.” [Continued here]